The federal government outlaws marijuana, but many states are legalizing it. Coupled with the growing number of cannabis-related patents, the potential for court battles is dizzying.
Academic rigour, journalistic flair
Articles on Patents
Displaying 61 - 80 of 112 articles
The high cost of cancer drugs in South Africa has come under the spotlight with an investigation by the Competition Commission in the country.
In March 2018, all Australian universities will be submitting key performance indicators (KPIs) on their engagement and impact to the Australian Research Council. These measure how well universities engage…
The UK is the latest country where tobacco companies cannot market their brands on their packets.
Elon Musk struck a blow for open IP, so should other sustainable industries go the same way?
American slaves couldn’t hold property – including patents on their own inventions. But that didn’t stop black Americans from innovating since the beginning of the country’s history.
The copyright wars are set to continue, with the government releasing a Productivity Commission report arguing for a relaxation of intellectual property laws.
The outgoing president leaves behind some solid accomplishments in the world of science, tech and medicine. But the biggest departure from his predecessors might have been in his approach.
The ruling in the Apple-Samsung case is ambiguous, ensuring the case will drag on for years more, potentially even ending up back in the Supreme Court.
If the UK is so intent on a ‘hard Brexit’, why did it just ratify a court that gives the EU jurisdiction over patent disputes?
The Supreme Court is considering two cases stemming from the merger of design and function that could reshape intellectual property law. Can we protect innovation without impeding fair competition?
Australia has never been short of inventors, scientists aren’t always at home in the ruthless world of commerce. But if they can be given a helping hand, it could help the entire economy.
Design patents cover how products look – but how much does appearance contribute to profits?
Why drug maker Mylan’s decision to introduce a half-price version of its EpiPen could be more than a publicity stunt.
Google saves $9 billion, programmers and users get to keep a popular language and its apps – and a key Oracle product stays alive.
The Productivity Commission’s report into copyright reform will be good for the public, good for innovation and good for Australia.
U.C. Berkeley and the Broad Institute are fighting to control the patents on the revolutionary gene-editing technology. But there’s a lot more at stake than just who gets the credit and licensing fees.
How scientists and corporations are plundering the developing world for new substances.
Motorola brought to market many features of mobile phones we take for granted, but it wasn’t enough.
Copyright law had to figure out how to deal with digital media. Now 3D printers – and their capacity for infringement – are poised to challenge the patent system in a similar way.
Top contributors
-
Reader in Intellectual Property Law, City, University of London
-
Associate Professor, School of Law, University of Canberra
-
Associate Professor in Public Health, La Trobe University
-
Professor of Law, University of Denver
-
Associate Professor of Public Policy and Women's Studies, University of Michigan
-
Lecturer in Law, Deakin Law School, Deakin University
-
Associate Professor of Law, Fordham University
-
Associate Professor, University of East Anglia
-
DST-NRF SARChI Chair in Innovation Studies, Tshwane University of Technology
-
Director, Centre for Transformative Innovation, Swinburne University of Technology
-
Professor and Distinguished Research Chair, Globalization and Health Equity, L’Université d’Ottawa/University of Ottawa
-
Senior Lecturer in Law, City, University of London
-
Tshwane University of Technology
-
Professor, College of Business, Zayed University
-
Honarary Associate Professor; economics of patents, copyright and other "IP", Australian National University
